Unlocking the Mysteries of the Human Microbiome to Combat COVID-19
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-in/article-image/Unlocking-the-Mysteries-of-the-Humanm-2.jpg0/jcr:content/Unlocking-the-Mysteries-of-the-Humanm-2.jpg)
The recent global dissemination of the novel coronavirus SARS-CoV-2 and the subsequent COVID-19 pandemic have galvanized the scientific community around the central goal of developing therapeutics for immediate and long-term treatment. Based on this study, it can be inferred that the human microbiome can have a profound impact on susceptibility to SARS-CoV-2 infection and COVID-19 severity. The involvement of gastrointestinal symptoms and respiratory illness in COVID-19 makes the gut and lung microbiota a potential target in COVID-19 management
![Unlocking the Mysteries of the Human Microbiome to Combat COVID-19](/.imaging/webp/sanofi-templates/w1080-16-9/dam/campus-sanofi-in/article-image/image-(28).jpg1/jcr:content/image%20(28).jpg)